AKT1 and acute lymphoblastic leukemia: Based on the above results, we suggest that the pharmacological inhibition of m6A demethylase activity of FTO by FB23‐2 successfully restored the IRF8 expression in T‐ALL in vivo, thus inhibiting the process of leukemogenesis via inhibition of PI3K/AKT signaling.